
Chinese General Practice ›› 2023, Vol. 26 ›› Issue (27): 3430-3434.DOI: 10.12114/j.issn.1007-9572.2023.0081
• Article • Previous Articles Next Articles
Received:2023-01-31
Revised:2023-03-11
Published:2023-09-20
Online:2023-03-23
Contact:
LIN Jia
通讯作者:
林佳
作者简介:基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0081
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | 高脂血症〔例(%)〕 | 吸烟史〔例(%)〕 | HGB (g/L) | PLT (×109/L) | CRP (mg/L) | ALB (g/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CCC形成良好组 | 52 | 36/16 | 64.5±6.8 | 38(73.1) | 13(25.0) | 30(57.7) | 15(28.8) | 135.36±13.79 | 183.36±49.98 | 6.86±4.08 | 45.95±3.85 |
| CCC形成不良组 | 83 | 51/32 | 66.0±7.3 | 53(63.9) | 40(48.2) | 45(54.2) | 39(47.0) | 133.42±13.55 | 193.48±52.26 | 11.84±5.26 | 41.53±5.10 |
| 检验统计量值 | 0.85a | -0.98 | 1.24a | 7.21a | 0.16a | 4.38a | 0.80 | -1.11 | -5.82 | 5.36 | |
| P值 | 0.358 | 0.330 | 0.266 | 0.007 | 0.692 | 0.036 | 0.420 | 0.270 | <0.001 | <0.001 | |
| 组别 | FBG (mmol/L) | TG (mmol/L) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | UA (μmol/L) | Scr (μmol/L) | BUN (mmol/L) | CAR 〔M(P25,P75),%〕 | ||
| CCC形成良好组 | 6.13±1.82 | 1.67±0.81 | 4.50±1.14 | 2.33±0.82 | 1.01±0.34 | 388.66±109.39 | 80.42±16.70 | 5.75±1.52 | 14.53(7.03,20.66) | ||
| CCC形成不良组 | 6.29±2.06 | 1.95±1.09 | 4.39±1.33 | 2.61±0.89 | 0.97±0.35 | 377.15±98.98 | 80.94±20.44 | 5.67±1.74 | 27.54(19.44,35.21) | ||
| 检验统计量值 | -0.48 | -1.59 | 0.50 | -1.86 | 0.68 | 0.63 | -0.16 | 0.25 | -6.10b | ||
| P值 | 0.630 | 0.120 | 0.620 | 0.065 | 0.490 | 0.530 | 0.880 | 0.800 | <0.001 |
Table 1 Comparison of clinical data between two groups
| 组别 | 例数 | 性别(男/女) | 年龄(岁) | 高血压〔例(%)〕 | 糖尿病〔例(%)〕 | 高脂血症〔例(%)〕 | 吸烟史〔例(%)〕 | HGB (g/L) | PLT (×109/L) | CRP (mg/L) | ALB (g/L) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CCC形成良好组 | 52 | 36/16 | 64.5±6.8 | 38(73.1) | 13(25.0) | 30(57.7) | 15(28.8) | 135.36±13.79 | 183.36±49.98 | 6.86±4.08 | 45.95±3.85 |
| CCC形成不良组 | 83 | 51/32 | 66.0±7.3 | 53(63.9) | 40(48.2) | 45(54.2) | 39(47.0) | 133.42±13.55 | 193.48±52.26 | 11.84±5.26 | 41.53±5.10 |
| 检验统计量值 | 0.85a | -0.98 | 1.24a | 7.21a | 0.16a | 4.38a | 0.80 | -1.11 | -5.82 | 5.36 | |
| P值 | 0.358 | 0.330 | 0.266 | 0.007 | 0.692 | 0.036 | 0.420 | 0.270 | <0.001 | <0.001 | |
| 组别 | FBG (mmol/L) | TG (mmol/L) | TC (mmol/L) | LDL-C (mmol/L) | HDL-C (mmol/L) | UA (μmol/L) | Scr (μmol/L) | BUN (mmol/L) | CAR 〔M(P25,P75),%〕 | ||
| CCC形成良好组 | 6.13±1.82 | 1.67±0.81 | 4.50±1.14 | 2.33±0.82 | 1.01±0.34 | 388.66±109.39 | 80.42±16.70 | 5.75±1.52 | 14.53(7.03,20.66) | ||
| CCC形成不良组 | 6.29±2.06 | 1.95±1.09 | 4.39±1.33 | 2.61±0.89 | 0.97±0.35 | 377.15±98.98 | 80.94±20.44 | 5.67±1.74 | 27.54(19.44,35.21) | ||
| 检验统计量值 | -0.48 | -1.59 | 0.50 | -1.86 | 0.68 | 0.63 | -0.16 | 0.25 | -6.10b | ||
| P值 | 0.630 | 0.120 | 0.620 | 0.065 | 0.490 | 0.530 | 0.880 | 0.800 | <0.001 |
| 自变量 | 单因素Logistic回归分析 | 多因素Logistic回归分析 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B | SE | Wald χ2值 | OR(95%CI) | P值 | B | SE | Wald χ2值 | OR(95%CI) | P值 | |
| 糖尿病 | 1.026 | 1.084 | 7.43 | 2.791(1.304,5.974) | 0.008 | 0.959 | 1.215 | 50.47 | 2.609(1.048,6.450) | 0.039 |
| 吸烟史 | 0.782 | 0.824 | 4.47 | 2.186(1.044,4.577) | 0.038 | 0.760 | 0.999 | 50.47 | 2.139(0.856,5.344) | 0.104 |
| CRP | 0.234 | 0.063 | 32.06 | 1.264(1.146,1.393) | <0.001 | |||||
| ALB | -0.214 | 0.039 | 26.92 | 0.808(0.735,0.887) | <0.001 | |||||
| TG | 0.291 | 0.248 | 2.55 | 1.338(0.930,1.925) | 0.117 | |||||
| LDL-C | 0.389 | 0.314 | 3.49 | 1.476(0.973,2.240) | 0.067 | |||||
| CAR | 0.120 | 0.027 | 42.23 | 1.128(1.077,1.181) | <0.001 | 0.125 | 0.029 | 50.47 | 1.134(1.078,1.192) | <0.001 |
Table 2 The results of univariate and multivariate Logistic regression analyses of influencing factors of poor-developed CCC in UAP patients
| 自变量 | 单因素Logistic回归分析 | 多因素Logistic回归分析 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| B | SE | Wald χ2值 | OR(95%CI) | P值 | B | SE | Wald χ2值 | OR(95%CI) | P值 | |
| 糖尿病 | 1.026 | 1.084 | 7.43 | 2.791(1.304,5.974) | 0.008 | 0.959 | 1.215 | 50.47 | 2.609(1.048,6.450) | 0.039 |
| 吸烟史 | 0.782 | 0.824 | 4.47 | 2.186(1.044,4.577) | 0.038 | 0.760 | 0.999 | 50.47 | 2.139(0.856,5.344) | 0.104 |
| CRP | 0.234 | 0.063 | 32.06 | 1.264(1.146,1.393) | <0.001 | |||||
| ALB | -0.214 | 0.039 | 26.92 | 0.808(0.735,0.887) | <0.001 | |||||
| TG | 0.291 | 0.248 | 2.55 | 1.338(0.930,1.925) | 0.117 | |||||
| LDL-C | 0.389 | 0.314 | 3.49 | 1.476(0.973,2.240) | 0.067 | |||||
| CAR | 0.120 | 0.027 | 42.23 | 1.128(1.077,1.181) | <0.001 | 0.125 | 0.029 | 50.47 | 1.134(1.078,1.192) | <0.001 |
| 指标 | 最佳截断值 | 灵敏度 | 特异度 | AUC(95%CI) | P值 |
|---|---|---|---|---|---|
| CRP | 8.42 mg/L | 0.735 | 0.712 | 0.771(0.691,0.851) | <0.01 |
| ALB | 43.63 g/L | 0.651 | 0.769 | 0.745(0.663,0.827) | <0.01 |
| CAR | 17.42% | 0.855 | 0.692 | 0.813(0.739,0.886) | <0.01 |
Table 3 Related indicators of CRP,ALB and CAR in predicting poor-developed CCC in UAP patients
| 指标 | 最佳截断值 | 灵敏度 | 特异度 | AUC(95%CI) | P值 |
|---|---|---|---|---|---|
| CRP | 8.42 mg/L | 0.735 | 0.712 | 0.771(0.691,0.851) | <0.01 |
| ALB | 43.63 g/L | 0.651 | 0.769 | 0.745(0.663,0.827) | <0.01 |
| CAR | 17.42% | 0.855 | 0.692 | 0.813(0.739,0.886) | <0.01 |
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J]. 中华心血管病杂志,2007,35(4):295-304. DOI:10.3760/j.issn:0253-3758.2007.04.003.
|
| [11] |
|
| [12] |
|
| [13] |
崔晓伟,谷国强. 冠状动脉侧支循环影响因素及评价方法的研究进展[J]. 心血管病学进展,2021,42(5):437-441. DOI:10.16806/j.cnki.issn.1004-3934.2021.05.013.
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||